Work

Carboplatin (Cb), weekly nanoparticle, albumin-bound paclitaxel (wAb), and bevacizumab (Av) neoadjuvant chemotherapy (NAC) in HER2-negative breast cancer (BrCA): A BrUOG study.

Year: 2011

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.29.15_suppl.e11573

Authors: N. Sinclair, M. M. Abu-Khalaf, B. J. Sakr, T. Rizack, D. R. Lannin, J. S. Gass, R. Strenger, V. Bossuyt, M. A. Fenton, L. Harris, W. M. Sikov

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559999375

Cites:

Cited by:

Related to: 10